Symbol
EPRX on Nasdaq
Investment type
Equity / Common Shares, with no par value
Latest Disclosed Ownership
5.53M shares
Security Ownership
10.2%

Joseph S. Freedman ownership in EUPRAXIA PHARMACEUTICALS INC. Common Shares, with no par value (EPRX)

2025-09-26 - Joseph S. Freedman has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.53M shares of EUPRAXIA PHARMACEUTICALS INC. Common Shares, with no par value (EPRX). This represents 10.2% percent ownership of the company.